{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-023016","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.654346+00:00","generated_at":"2026-06-13T13:49:59.832337+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"TRxADE Health to acquire Superlatus, shifting to food & snack industry; new shares to be issued.","bullets":["Superlatus shareholders receive 173,463 MEDS shares (136,436 common, 37,027 Series B preferred convertible at 100:1).","MEDS to divest its existing operating business and assets shortly after the merger closes.","Superlatus must acquire Prestige Farms and Sapientia; valuation must be at least $225M.","Combined company to create global consolidation platform for food and healthy snacks.","Merger expected to close in late Q3 or early Q4 2023; Boards unanimously approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-023016","json":"https://secwatch.observer/filing/0001493152-23-023016.json","markdown":"https://secwatch.observer/filing/0001493152-23-023016.md","text":"https://secwatch.observer/filing/0001493152-23-023016.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/0001493152-23-023016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:49:59.832337+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"22779dadf28afe270a1ffd5c4564c73f92a3575d","claim":"Scienture Holdings, Inc. entered into Agreement and Plan of Merger with Superlatus Inc. (effective 2023-06-30).","evidence_excerpt":"On June 30, 2023, TRxADE Health, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Superlatus Inc., a Delaware corporation (“Superlatus”), and Foods Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315223023016/0001493152-23-023016-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"merger"},{"label":"Counterparty","value":"Superlatus Inc."},{"label":"Effective","value":"2023-06-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}